Search for a command to run...
Promoter shareholding unchanged, indicating stability but lack of new investment confidence.
Institutional selling (-1.01% YoY, -0.33% QoQ), diverging from sector average, signals potential issues with Hikal Ltd.
Public interest slightly increased, but overall sentiment suggests caution in the Pharma sector, especially compared to top performers.
| Category | Trend | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|
1Promoter37 | 68.85% | 68.85% | 68.85% | 68.85% | 68.85% | 68.85% | 68.85% | 68.85% | |
2Institution3 | 5.79% | 6.72% | 7.03% | 7.08% | 6.88% | 6.35% | 6.02% | 4.13% | |
3Public2 | 0.57% | 0.5% | 0.33% | 0.36% | 0.36% | 0.36% | 0.38% | 0.4% |